Notably, PHF20L1 was highly amplified in several cancers, including ovarian serous cystadenocarcinoma, breast cancer, liver cancer, and pancreatic adenocarcinoma, suggesting that it may play a critical role in tumourigenesis (Figure 4C). This evidence concerns the gene PHF20L1 and breast carcinoma.